A comparative study of prophylactic ondansetron versus palonosetron for post operative nausea and vomiting in middle ear surgeries
DOI:
https://doi.org/10.7439/ijbar.v5i12.988Abstract
Objectives-Postoperative nausea and vomiting (PONV) is a common complication in patients undergone middle ear surgeries under general anaesthesia. The purpose of this study was to compare antiemetic efficacy of prophylactic palonosetron in comparison with ondansetron, administered intravenously in patients undergoing middle ear surgeries under general anaesthesia. Methods-In this prospective, randomized, clinically controlled study 60 ASA grade-I and II patients of either sex, aged between 18 to 50 years, scheduled for middle ear surgery under general anaesthesia were randomly allocated to one of the two groups, group O (n=30), received Inj. ondansetron 8mg I.V., and group P (n=30), received Inj. palonosetron 0.075mg I.V. before induction of anaesthesia. Postoperatively incidence of nausea, vomiting, complete response and need for rescue antiemetics over first 24hrs after surgery were evaluated. Results-The overall incidence of nausea, vomiting once and vomiting more than once, in first 24hrs was higher in ondansetron group than in palonosetron group i.e. 56.66%, 20%, 3.3% and 30%, 3.33%, 0% respectively, and significant statistically (p 0.05). Only 40% patients in group O while 73.3% in group P showed complete response (p=0.009). Number of patients requiring rescue antiemetic were more in group O than group P (p=0.044). Haemodynamically no any major changes were observed in either group. Conclusion-Our study concludes that prophylactic palonosetron 0.075mg IV is more effective than ondansetron 8mg IV for prevention of post operative nausea and vomiting in patients undergoing middle ear surgeries under general anaesthesia.Downloads
Download data is not yet available.
Downloads
Published
2014-12-30
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
A comparative study of prophylactic ondansetron versus palonosetron for post operative nausea and vomiting in middle ear surgeries. (2014). International Journal of Biomedical and Advance Research, 5(12), 619-622. https://doi.org/10.7439/ijbar.v5i12.988